Efficacy of Different Doses of Amino Acids in 5AA+CrPic Water on Glucose Homeostasis in a Healthy Population.
NCT ID: NCT03411395
Last Updated: 2018-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2016-10-13
2016-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Artificial Sweeteners or Sugar on Hemodynamic and Metabolic Stress Responses
NCT02973334
Short-term Sugary Beverage Consumption on Glucose Control and Cardiovascular Disease Risk Factors
NCT04118257
Effect of Amino Acid Addition to a Drink on the Appearance of Ingested Water in Body Fluids1
NCT04819334
Brain and Glycemic Responses to Sweet Soft Drinks
NCT05575687
Comparison of the Effects of a 12-Week Consumption of Two Carbonated Beverages on Insulin Sensitivity
NCT02031497
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo drink
A standardized breakfast meal will be provided together with carbonated water containing aroma
Placebo drink
Placebo water with carbonation and aroma
5AA+CrPic Water Dose 1
A standardized breakfast meal will be provided together with carbonated water containing aroma and active components 5AA and CrPic
5AA+CrPic Water
Dietary supplement drink with carbonation, aroma, amino acids and chromium picolinate
5AA+CrPic Water Dose 2
A standardized breakfast meal will be provided together with carbonated water containing aroma and active components 5AA (1/2 of Dose 1) and CrPic
5AA+CrPic Water
Dietary supplement drink with carbonation, aroma, amino acids and chromium picolinate
5AA+CrPic Water Dose 3
A standardized breakfast meal will be provided together with carbonated water containing aroma and active components 5AA (1/4 of Dose 1) and CrPic
5AA+CrPic Water
Dietary supplement drink with carbonation, aroma, amino acids and chromium picolinate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
5AA+CrPic Water
Dietary supplement drink with carbonation, aroma, amino acids and chromium picolinate
Placebo drink
Placebo water with carbonation and aroma
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Agree to maintain consistent dietary habits and physical activity levels for the duration of the study
* Healthy as determined by medical history and information provided by the volunteer
* Willingness to complete questionnaires and follow instructions associated with the study and to complete all visits
* Has given voluntary, written, informed consent to participate in the study
Exclusion Criteria
* Known Type I or Type II diabetes
* Undetected Type I or Type II diabetes (fasting blood glucose \< 6.1 mmol/L at first test day)
* Use of antibiotics
* Metabolic diseases and/or chronic gastrointestinal diseases (IBS, Crohns etc.)
* Allergy to test product or placebo ingredients
* Participants restricted to a vegetarian or vegan diet
* Intolerance to lactose or gluten
* Acute infection
* Individuals who are averse to venous catheterization or capillary blood sampling
* Alcohol or drug abuse
* Currently active smokers (tobacco products, and e-cigarettes)
* Participation in other clinical research trials
* Individuals who are cognitively impaired and/or who are unable to give informed consent
* Any other condition which in the PI's opinion may adversely affect the individual's ability to complete the study or its measures or which may pose significant risk to the individual
* Any medical condition(s) or medication(s) known to significantly affect glucose metabolism. Significance to be assessed by the PI
* Use of medication, over-the-counter medication, natural health products or dietary supplements/probiotics that may affect glucose metabolism is prohibited during this study. Significance to be assessed by the PI. Participants who are taking allowed prescribed medications must agree to maintain their current method and dosing regimen during the course of the study unless recommended by their physician.
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lund University
OTHER
Aventure AB
INDUSTRY
DoubleGood AB
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elin Östman, PhD
Role: PRINCIPAL_INVESTIGATOR
Scheelevägen 22 223 63 Lund, Sweden
Kristina Andersson, PhD
Role: STUDY_DIRECTOR
Experimental Medical Science, Lund University, Sweden
Lovisa Heyman-Lindén, PhD
Role: STUDY_CHAIR
Scheelevägen 22 223 63 Lund, Sweden
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DG1603Lund
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.